Cheryl C. Ho

600 W 10th Ave, V5Z 4E6
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer.

CT surveillance, patterns of recurrence and eligibility for salvage therapy after curative intent treatment for unresectable stage III non small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 27, 2026

Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.

Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.

Journal: Journal of clinical medicine

Published: April 30, 2026

Investigating fine-tuning versus zero-shot learning for general large language models when predicting cancer survival from initial oncology consultation documents.

Investigating fine-tuning versus zero-shot learning for general large language models when predicting cancer survival from initial oncology consultation documents.

Journal: ESMO real world data and digital oncology

Published: April 20, 2026

A Response to the Letter to the Editor.

A Response to the Letter to the Editor.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 01, 2026

Not Always ICANS: Interpreting Neurotoxicity With Tarlatamab in SCLC.

Not Always ICANS: Interpreting Neurotoxicity With Tarlatamab in SCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 28, 2026

Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE).

Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE).

Journal: JTO clinical and research reports

Published: March 11, 2026

Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840].

Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840].

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 17, 2025

Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials.

Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: October 17, 2025

Molecular characterization of salivary cancers: Patterns of genomic alterations and potential for impact on therapeutic choices.

Molecular characterization of salivary cancers: Patterns of genomic alterations and potential for impact on therapeutic choices.

Journal: Cancer treatment and research communications

Published: September 29, 2025

Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort.

Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort.

Journal: Asia-Pacific journal of clinical oncology

Published: August 21, 2025

Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviews.

Adopting life-cycle HTA: a tumor-agnostic precision oncology index economic evaluation from publicly available reimbursement reviews.

Journal: International journal of technology assessment in health care

Published: June 24, 2025

Ultrarapid EGFR Testing in Non-Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing Workflow.

Ultrarapid EGFR Testing in Non-Small Cell Lung Carcinoma Patients: Findings From a Canadian Clinical Testing Workflow.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: May 24, 2025

Showing 1-12 of 136

Last Updated: 09/26/2026